| SQM price and market capitalization | $67.06 at the July 31, 2026 close and $19.15 billion market capitalization | StockAnalysis.com real-time quote and statistics | August 2, 2026 |
| Shares outstanding and market-cap verification | 285.64 million shares; $67.06 x 285.64 million = $19.16 billion, 0.03 percent from reported market cap | StockAnalysis.com and Pineify financial_rigor.py | August 2, 2026 |
| FY2025 revenue | $4,576.2 million, cross-validated against the SQM 20-F, StockAnalysis.com, and the Q4 2025 earnings release with 0.00% deviation | SQM 2025 annual report on SEC EDGAR | August 2, 2026 |
| FY2025 net income attributable to controlling interests | $588.1 million, cross-validated against the SQM 20-F and StockAnalysis.com with 0.00% deviation | SQM 2025 annual report on SEC EDGAR | August 2, 2026 |
| FY2025 earnings per share | $2.06 basic earnings per share | SQM 2025 annual report on SEC EDGAR | August 2, 2026 |
| FY2025 adjusted EBITDA | $1,579.6 million, compared with $1,483.6 million in FY2024 | SQM 2025 annual report on SEC EDGAR | August 2, 2026 |
| Q1 2026 revenue and net income | $1,760.1 million revenue up 69.8% and $364.7 million net income or $1.28 per share, cross-validated against StockAnalysis.com and the earnings release with 0.00% to 0.01% deviation | SQM Q1 2026 earnings release (6-K) | May 26, 2026 |
| Q1 2026 gross profit and adjusted EBITDA | Gross profit of $778.6 million at a 44.2% margin and adjusted EBITDA of $837.0 million at a 47.6% margin | SQM Q1 2026 earnings release (6-K) | May 26, 2026 |
| Q1 2026 lithium results | Revenue of $1,185.5 million up 135.7%, volumes of about 69,000 metric tons of LCE up 25%, and an average realized price near $17.8 per kilogram up about 95% year over year | SQM Q1 2026 earnings release (6-K) | May 26, 2026 |
| 2026 lithium volume guidance | Lithium sales volumes raised to about 15% growth for 2026, with global lithium demand estimated above 1.9 million metric tons of LCE | SQM Q1 2026 earnings release (6-K) | May 26, 2026 |
| Q1 2026 specialty plant nutrition results | Revenue of $239.0 million up 12.6% on volumes up 7%, with full-year 2026 sales volume guidance raised to at least 10% growth | SQM Q1 2026 earnings release (6-K) | May 26, 2026 |
| Q1 2026 iodine and potassium results | Iodine revenue of $275.9 million up 8.2% at an average price of $72.3 per kilogram; potassium revenue of $34.4 million down 19% with 2026 volumes guided down about 50% | SQM Q1 2026 earnings release (6-K) | May 26, 2026 |
| Balance sheet as of March 31, 2026 | Cash and cash equivalents of $2,829.4 million, short-term debt of $324.4 million, long-term debt of $4,787.5 million, total assets of $15,779.5 million, and shareholders equity before minority interest of $5,852.2 million | SQM Q1 2026 earnings release (6-K) and interim statements | May 26, 2026 |
| Cash and debt reconciliation | StockAnalysis.com reports cash and investments of $3,867 million, which equals company cash of $2,829.4 million plus other current financial assets of $1,038.1 million; total debt of $5,208 million and net debt of about $1.3 billion | SQM Q1 2026 interim statements and StockAnalysis.com balance sheet | August 2, 2026 |
| Codelco partnership | Association agreement completed December 27, 2025 through the merger of Minera Tarar into SQM Salar, renamed Nova Andino Litio; first full quarter generated more than $530 million in contributions to the Chilean state; merger subject to a pending Supreme Court appeal | SQM press release (6-K) and Q1 2026 earnings release | December 27, 2025 |
| Mt Holland expansion final investment decision | SQM and Wesfarmers approved the expansion on July 21, 2026, doubling spodumene concentrate to about 760,000 tonnes per year at 5.5% Li2O, with SQM capital expenditure of about $450 million to $500 million, construction from the second half of 2027 and first production from the first half of 2030 | SQM and Wesfarmers press release (6-K) | July 21, 2026 |
| TTM financial summary | TTM revenue of $5.30 billion, TTM net income of $815.33 million, TTM EPS of $2.85, operating cash flow of $1.96 billion, capital expenditures of $877.3 million, and free cash flow of $1.08 billion | StockAnalysis.com statistics and cash flow statement | August 2, 2026 |
| Valuation check | 23.49x trailing EPS, 3.61x sales, 3.27x book value, 17.67x free cash flow, 0.99% dividend yield | StockAnalysis.com statistics | August 2, 2026 |
| Forward valuation | Forward PE of 8.27x, forward PS of 2.25x, EV/EBITDA of 28.44, EV/FCF of 18.92, PEG of 0.17 | StockAnalysis.com statistics | August 2, 2026 |
| Analyst consensus | Buy with an average price target of $84.78 across 18 analysts, low $44.35, median $86.85, and high $110 | StockAnalysis.com forecast and analyst ratings | July 28, 2026 |
| Recent analyst target updates | Scotiabank Buy with target lowered to $93 from $105, Goldman Sachs Neutral raised to $82 from $64, Deutsche Bank Buy lowered to $98 from $105, Berenberg Hold raised to $66 from $56, J.P. Morgan Neutral after a downgrade from Overweight with a target of $100 | StockAnalysis.com forecast and TipRanks | July 28, 2026 |
| FY2026 consensus estimate | Revenue of $7.98 billion, up about 74% from FY2025, and net income of $1.86 billion, which implies EPS near $6.51 | StockAnalysis.com forecast financial forecast | July 28, 2026 |
| 52-week range and price change | 52-week range of $35.67 to $98.00, with the stock up 79.45% over the last 52 weeks and down 31.6% from its high | StockAnalysis.com quote and statistics | August 2, 2026 |
| Short interest | 2.19 million shares short, 1.64% of shares outstanding, 2.25 days to cover | StockAnalysis.com statistics short selling | August 2, 2026 |
| Next earnings date | Tuesday, August 18, 2026, after market close | StockAnalysis.com earnings calendar | August 2, 2026 |
| Technical snapshot | 20-day SMA near $70.18, 50-day SMA near $75.15, 100-day SMA near $79.75, 200-day SMA near $72.61, 14-day RSI near 38.22, 14-day ADX near 27.5, 14-day historical volatility near 45.1% | Barchart and StockAnalysis.com technical snapshots | August 2, 2026 |